AIRS Medical announced that it has received a strategic growth investment from TA Associates, which will support the company’s next phase of international expansion, product innovation, and advancement of its AI-powered radiology technologies.
Founded in 2018, AIRS Medical develops AI-native magnetic resonance imaging software designed to enhance MRI speed, image quality, and workflow performance. The company currently supports more than 1,700 healthcare institutions across over 40 countries, with its technologies used in more than 6 million MRI examinations annually.
Healthcare organizations and academic institutions have increasingly adopted AIRS Medical’s solutions as providers seek to address growing imaging demand and capacity constraints while maximizing the value of existing infrastructure.
The company’s portfolio includes SwiftMR, an AI-powered MRI acceleration and image enhancement solution, and SwiftSight, an MRI quantification and structured reporting platform. Together, the products provide healthcare organizations with capabilities spanning image acquisition through clinical interpretation.
AIRS Medical said the investment from TA will help accelerate product development and expand its international presence as demand grows for technologies that improve imaging efficiency and patient access.
TA Associates noted that AIRS Medical has established itself as an AI-native medical technology company addressing capacity and workflow challenges faced by radiology providers worldwide. The private equity firm highlighted the company’s growing footprint across more than 40 countries and its position at the intersection of artificial intelligence, medical imaging, and healthcare operations.
Financial terms of the transaction were not disclosed. The deal is expected to close during the second quarter of 2026, subject to customary closing conditions.
Founded in 1968, TA Associates has invested in more than 560 companies across technology, healthcare, business services, and financial services and has raised $65 billion in capital to date.
KEY QUOTES:
“MRI scanners are among the most valuable assets in healthcare, yet many providers continue to struggle with growing imaging demand and limited capacity. We are pleased to partner with TA to further advance our mission to increase accessibility to advanced diagnostics and deliver greater value for patients and providers globally.”
Dr. Hyeseong Lee, Co-Founder and Chairman of AIRS Medical
“This investment marks an important milestone in AIRS Medical’s growth journey. Demand for technologies that improve MRI efficiency and expand patient access continues to grow globally. With TA’s support, we will accelerate product innovation, expand our international footprint and continue helping healthcare providers unlock greater value from their existing MRI infrastructure.”
Jason Park, Chief Executive Officer of AIRS Medical
“As an AI-native medical technology leader, AIRS Medical has developed a differentiated AI platform that addresses critical capacity and workflow challenges facing radiology providers globally. The Company’s strong foundation and growing international presence across 40+ countries position it well to meet increasing demand for solutions that improve imaging efficiency, patient access and diagnostic consistency.”
Edward Sippel, Managing Director and Head of TA Asia Pacific
“TA has a long history of partnering with innovative healthcare technology companies that help providers deliver better patient outcomes. We are excited to partner with the entire AIRS Medical team as they build on their strong momentum, expand their market leadership and continue delivering meaningful value to providers and patients worldwide.”
Michele Lim, Senior Vice President at TA
